Transaction #16300 · Form 4 · 0001568605-25-000005
Sana Biotechnology, Inc. · Stock award · Stock Option (Right to Buy)
Sana Biotechnology, Inc. · Transacted December 13, 2024 · Filed December 5, 2025
What does this filing report?
An SEC Form 4 filing for Sana Biotechnology, Inc. records a stock award involving Stock Option (Right to Buy) on December 13, 2024. The reported quantity was 5,100. The filing date is December 5, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Sana Biotechnology, Inc.
- Company CIK
- 0001770121
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 5,100
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 5,100
- Ownership description
- Not reported
- SEC acceptance time
- Dec 5, 2025, 5:04 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Wyrick Susan D. ↗
See Remarks
CIK 0001568605
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 5,100
- Conversion / exercise price
- 1.89
- Exercise date
- Not reported
- Expiration date
- December 12, 2034
Filing footnotes & remarks
- F1
- This transaction is being reported late due to an inadvertent administrative error and not any error of the reporting person.
- F2
- Includes 3,000 shares acquired on May 15, 2025 pursuant to Sana Biotechnology, Inc.'s ("Sana") 2021 Employee Stock Purchase Plan (the "ESPP").
- F3
- Includes 3,000 shares acquired on November 14, 2025 pursuant to the ESPP.
- F4
- Each restricted stock unit represents a contingent right to receive one share of Sana common stock.
- F5
- The award vests as to 100% of the restricted stock units on December 13, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.
- F6
- The option vests as to 100% of the shares underlying the option on January 13, 2026, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.
- F7
- The restricted stock units vested in two equal installments on each of June 3, 2025 and December 3, 2025.
Remarks
Acting Chief Financial Officer and Principal Accounting Officer; Exhibit List: Ex. 24 - Power of Attorney
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.